Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Besylate Plus Fentanyl for Colonoscopy Sedation (Phase II, CTR20170378)
CTR20170378Phase 2Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of remimazolam, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Nov 2017; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on CTR20170378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170378.